阿那曲唑
医学
内科学
危险系数
比例危险模型
乳腺癌
肿瘤科
置信区间
化疗
芳香化酶抑制剂
妇科
癌症
三苯氧胺
作者
Senna W. M. Lammers,Sandra M. E. Geurts,Karlijn E. P. E. Hermans,Irene E. G. van Hellemond,Astrid C. P. Swinkels,Carolien H. Smorenburg,Ate van der Gaast,Judith R. Kroep,Aafke H. Honkoop,Franchette W. P. J. van den Berkmortel,W Roos,Alexander L. T. Imholz,Ingeborg J. H. Vriens,Vivianne C. G. Tjan‐Heijnen
标识
DOI:10.1007/s10549-024-07411-w
摘要
Patients with chemotherapy-induced ovarian function failure (CIOFF) may experience ovarian function recovery (OFR). Earlier, we showed that OFR during treatment with anastrozole impacted the prognosis of hormone receptor-positive (HR+) breast cancer (BC) patients with CIOFF. Here, we present the long-term follow-up results.
科研通智能强力驱动
Strongly Powered by AbleSci AI